Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report.
Allogeneic bone marrow transplantation
Allogeneic hematopoietic stem cell transplantation
Anaplastic large cell lymphoma
Anaplastic lymphoma kinase
Esophageal atresia
Esophageal obstruction
Esophageal stricture
Esophagectomy
Journal
Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125
Informations de publication
Date de publication:
05 Feb 2021
05 Feb 2021
Historique:
received:
09
11
2020
accepted:
02
01
2021
entrez:
5
2
2021
pubmed:
6
2
2021
medline:
6
2
2021
Statut:
epublish
Résumé
Anaplastic large cell lymphoma (ALCL) is a CD30-positive T-cell lymphoma, which is a rare type of non-Hodgkin lymphoma. ALCL rarely presents in the gastrointestinal tract, and the esophageal involvement in of ALCL is extremely rare. An 11-year-old boy who complained of abdominal pain and cough was diagnosed with ALK-positive ALCL on the basis of systemic lymphadenopathy findings and immunohistochemistry results of pleural effusion. Although remission was observed after chemotherapy at 5 months after diagnosis, dysphagia persisted, and esophagoscopy revealed a severe stricture in the middle thoracic esophagus. At 9 months after diagnosis, allogeneic bone marrow transplantation was performed to ensure that complete remission was maintained; however, dysphagia and saliva retention did not improve. Approximately 10 months after diagnosis, esophagoscopy revealed a blind end in the middle thoracic esophagus, similar to that in congenital esophageal atresia. Subsequently, we performed minimally invasive subtotal esophagectomy under thoracoscopy and laparoscopy and gastric conduit reconstruction via the retrosternal route more than 2 years after allogeneic bone marrow transplantation. The final pathological diagnosis was esophageal atresia with esophagitis, with no malignancy. During postoperative evaluation, the patient required swallowing training for a few months, although no major complications were noted. Oral intake was possible, and complete remission was maintained at 14 month post-surgery. Oncologists must consider the possibility of acquired esophageal cicatricial atresia as a complication during chemotherapy for ALCL. If esophageal obstruction or esophageal atresia occur and if remission is maintained, esophagectomy and esophageal reconstruction are useful treatment options for maintaining oral intake.
Sections du résumé
BACKGROUND
BACKGROUND
Anaplastic large cell lymphoma (ALCL) is a CD30-positive T-cell lymphoma, which is a rare type of non-Hodgkin lymphoma. ALCL rarely presents in the gastrointestinal tract, and the esophageal involvement in of ALCL is extremely rare.
CASE PRESENTATION
METHODS
An 11-year-old boy who complained of abdominal pain and cough was diagnosed with ALK-positive ALCL on the basis of systemic lymphadenopathy findings and immunohistochemistry results of pleural effusion. Although remission was observed after chemotherapy at 5 months after diagnosis, dysphagia persisted, and esophagoscopy revealed a severe stricture in the middle thoracic esophagus. At 9 months after diagnosis, allogeneic bone marrow transplantation was performed to ensure that complete remission was maintained; however, dysphagia and saliva retention did not improve. Approximately 10 months after diagnosis, esophagoscopy revealed a blind end in the middle thoracic esophagus, similar to that in congenital esophageal atresia. Subsequently, we performed minimally invasive subtotal esophagectomy under thoracoscopy and laparoscopy and gastric conduit reconstruction via the retrosternal route more than 2 years after allogeneic bone marrow transplantation. The final pathological diagnosis was esophageal atresia with esophagitis, with no malignancy. During postoperative evaluation, the patient required swallowing training for a few months, although no major complications were noted. Oral intake was possible, and complete remission was maintained at 14 month post-surgery.
CONCLUSIONS
CONCLUSIONS
Oncologists must consider the possibility of acquired esophageal cicatricial atresia as a complication during chemotherapy for ALCL. If esophageal obstruction or esophageal atresia occur and if remission is maintained, esophagectomy and esophageal reconstruction are useful treatment options for maintaining oral intake.
Identifiants
pubmed: 33544280
doi: 10.1186/s40792-021-01108-8
pii: 10.1186/s40792-021-01108-8
pmc: PMC7865044
doi:
Types de publication
Journal Article
Langues
eng
Pagination
41Références
Cancer Treat Rev. 1989 Jun;16 Suppl A:15-9
pubmed: 2670211
Crit Rev Oncol Hematol. 2012 Aug;83(2):293-302
pubmed: 22440390
Head Neck. 2008 Sep;30(9):1264-8
pubmed: 18228520
Gastroenterol Hepatol Bed Bench. 2017 Fall;10(4):332-336
pubmed: 29379600
Semin Pediatr Surg. 2017 Apr;26(2):72-77
pubmed: 28550874
J Pediatr Surg. 2004 Jul;39(7):e1-6
pubmed: 15213935
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1093-9
pubmed: 26240009
J Pediatr Surg. 2006 Mar;41(3):495-9
pubmed: 16516623
Semin Pediatr Surg. 2017 Apr;26(2):105-115
pubmed: 28550868
J Gastrointest Cancer. 2011 Mar;42(1):57-60
pubmed: 20524084
Pediatr Radiol. 2012 May;42(5):627-31
pubmed: 21877113
Cancer. 1992 Nov 15;70(10):2517-23
pubmed: 1330283
ACG Case Rep J. 2017 Aug 16;4:e99
pubmed: 28848771
Cancer. 1991 Jul 15;68(2):418-21
pubmed: 1648999
Blood. 2008 Jun 15;111(12):5496-504
pubmed: 18385450
Bone Marrow Transplant. 2001 Jun;27(12):1275-81
pubmed: 11548845
J Neonatal Surg. 2012 Jan 01;1(1):4
pubmed: 26023363
Eur J Pediatr Surg. 2012 Dec;22(6):420-5
pubmed: 23212741
Singapore Med J. 2008 Oct;49(10):e289-92
pubmed: 18946602
Asian J Endosc Surg. 2019 Jul;12(3):366-371
pubmed: 30549226
J Pediatr Hematol Oncol. 2010 Mar;32(2):124-7
pubmed: 20168244
Pediatr Blood Cancer. 2011 Jul 1;56(7):1071-7
pubmed: 21280197
J Pediatr Surg. 2017 Sep;52(9):1398-1408
pubmed: 28625693
J Pediatr Surg. 2014 Jun;49(6):849-52
pubmed: 24888821
World J Clin Cases. 2019 Oct 26;7(20):3377-3383
pubmed: 31667195
Eur J Pediatr Surg. 2013 Jun;23(3):198-203
pubmed: 23720207
J Pediatr Surg. 2010 Jun;45(6):1383-4
pubmed: 20620352
J Pediatr Surg. 2000 Mar;35(3):505-7
pubmed: 10726699